Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers

被引：0
|
作者：
Bernadette A. M. Heemskerk-Gerritsen
Agnes Jager
Linetta B. Koppert
A. Inge-Marie Obdeijn
Margriet Collée
Hanne E. J. Meijers-Heijboer
Denise J. Jenner
Hester S. A. Oldenburg
Klaartje van Engelen
Jakob de Vries
Christi J. van Asperen
Peter Devilee
Marinus J. Blok
C. Marleen Kets
Margreet G. E. M. Ausems
Caroline Seynaeve
Matti A. Rookus
Maartje J. Hooning
机构：
[1] Erasmus MC Cancer Institute,Department of Medical Oncology
[2] Erasmus MC Cancer Institute,Department of Surgery
[3] Erasmus MC Cancer Institute,Department of Radiology
[4] Erasmus MC Cancer Institute,Department of Clinical Genetics
[5] Academic Medical Center,Department of Clinical Genetics
[6] Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital,Department of Epidemiology
[7] Netherlands Cancer Institute,Department of Surgery
[8] VU University Medical Center,Department of Clinical Genetics
[9] University Medical Center Groningen,Department of Surgery
[10] Leiden University Medical Center,Department of Clinical Genetics
[11] Leiden University Medical Center,Department of Human Genetics
[12] Maastricht University Medical Center,Department of Clinical Genetics
[13] Radboud University Medical Center,Department of Human Genetics
[14] University Medical Center Utrecht,Department of Medical Genetics
来源：
Breast Cancer Research and Treatment | 2019年 / 177卷
关键词：
Bilateral risk-reducing mastectomy; Prevention; Surveillance; Survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：723 / 733
页数：10
相关论文
共 50 条
  • [41] Risk-reducing mastectomy and salpingo-oophorectomy in unaffected BRCA mutation carriers: uptake and timing*
    Skytte, A-B
    Gerdes, A-M
    Andersen, M. K.
    Sunde, L.
    Brondum-Nielsen, K.
    Waldstrom, M.
    Kolvraa, S.
    Crueger, D.
    CLINICAL GENETICS, 2010, 77 (04) : 342 - 349
  • [42] The risk of primary and contralateral breast cancer after ovarian cancer in BRCA1/BRCA2 mutation carriers Implications for Counseling
    Vencken, Peggy M. L. H.
    Kriege, Mieke
    Hooning, Maartje
    Menke-Pluymers, Marian B.
    Heemskerk-Gerritsen, Bernadette A. M.
    van Doorn, Lena C.
    Collee, Margriet M.
    Jager, Agnes
    van Montfort, Cees
    Burger, Curt W.
    Seynaeve, Caroline
    CANCER, 2013, 119 (05) : 955 - 962
  • [43] Association of Risk-Reducing Salpingo-Oophorectomy With Breast Cancer Risk in Women With BRCA1 and BRCA2 Pathogenic Variants
    Choi, Yun-Hee
    Terry, Mary Beth
    Daly, Mary B.
    MacInnis, Robert J.
    Hopper, John L.
    Colonna, Sarah
    Buys, Saundra S.
    Andrulis, Irene L.
    John, Esther M.
    Kurian, Allison W.
    Briollais, Laurent
    JAMA ONCOLOGY, 2021, 7 (04) : 585 - 592
  • [44] Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation
    Kotsopoulos, Joanne
    Gronwald, Jacek
    Huzarski, Tomasz
    Aeilts, Amber
    Armel, Susan Randall
    Karlan, Beth
    Singer, Christian
    Eisen, Andrea
    Tung, Nadine
    Olopade, Olufunmilayo
    Bordeleau, Louise
    Eng, Charis
    Foulkes, William
    Neuhausen, Susan
    Cullinane, Carey
    Pal, Tuya
    Fruscio, Robert
    Lubinski, Jan
    Metcalfe, Kelly
    Sun, Ping
    Narod, Steven
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 201 (02) : 257 - 264
  • [45] Survival and recurrence after breast cancer in BRCA1/2 mutation carriers
    El-Tamer, M
    Russo, D
    Troxel, A
    Bernardino, LP
    Mazziotta, R
    Estabrook, A
    Ditkoff, BA
    Schnabel, F
    Mansukhani, M
    ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (02) : 157 - 164
  • [46] Survival and Recurrence After Breast Cancer in BRCA1/2 Mutation Carriers
    Mahmoud El-Tamer
    Donna Russo
    Andrea Troxel
    Lourdes P. Bernardino
    Robert Mazziotta
    Alison Estabrook
    Beth-Ann Ditkoff
    Freya Schnabel
    Mahesh Mansukhani
    Annals of Surgical Oncology, 2004, 11 : 157 - 164
  • [47] International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers
    Metcalfe, Kelly A.
    Birenbaum-Carmeli, Daphna
    Lubinski, Jan
    Gronwald, Jacek
    Lynch, Henry
    Moller, Pal
    Ghadirian, Parviz
    Foulkes, William D.
    Klijn, Jan
    Friedman, Eitan
    Kim-Sing, Charmaine
    Ainsworth, Peter
    Rosen, Barry
    Domchek, Susan
    Wagner, Teresa
    Tung, Nadine
    Manoukian, Siranoush
    Couch, Fergus
    Sun, Ping
    Narod, Steven A.
    INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (09) : 2017 - 2022
  • [48] Cost Effectiveness of Risk-Reducing Mastectomy versus Surveillance in BRCA Mutation Carriers with a History of Ovarian Cancer
    Gamble, Charlotte
    Havrilesky, Laura J.
    Myers, Evan R.
    Chino, Junzo P.
    Hollenbeck, Scott
    Plichta, Jennifer K.
    Marcom, P. Kelly
    Hwang, E. Shelley
    Kauff, Noah D.
    Greenup, Rachel A.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (11) : 3116 - 3123
  • [49] The efficacy of taxane chemotherapy for metastatic breast cancer in BRCA1 and BRCA2 mutation carriers
    Kriege, Mieke
    Jager, Agnes
    Hooning, Maartje J.
    Huijskens, Elisabeth
    Blom, Jannet
    van Deurzen, Carolien H. M.
    Bontenbal, Marijke
    Collee, J. Margriet
    Menke-Pluijmers, Marian B. E.
    Martens, John W. M.
    Seynaeve, Caroline
    CANCER, 2012, 118 (04) : 899 - 907
  • [50] Preoperative diagnosis of BRCA1/2 mutation impacts decision-making for risk-reducing mastectomy in breast cancer patients
    Woo, Jinsun
    Gwak, Geumhee
    Park, Inseok
    Bae, Byung Noe
    Lee, Se Kyung
    Chae, Byung Joo
    Yu, Jonghan
    Lee, Jeong Eon
    Kim, Seok Won
    Nam, Seok Jin
    Ryu, Jai Min
    SCIENTIFIC REPORTS, 2021, 11 (01)
12345